Tabula Rasa Healthcare

Tabula Rasa Healthcare, Inc. is a healthcare technology company, which engages in the development of solutions designed for pharmacists, providers, and patients to optimize medication regimens. It operates through the following segments: CareVention HealthCare and MedWise HealthCare. The CareVention HealthCare segment provides services, PACE, which is a center for Medicare & Medicaid services, or CMS, sponsored program providing medical and social services. Its brands include CareKinesis, Capstone Risk Adjustment Services, PACElogic, TruChart, PeakTPA, PersonifilRx, and Pharmastar. The MedWise HealthCare segment provides Medication Therapy Management, or MTM, software and services for Medicare, Medicaid, and commercial health plans, and also provides a cloud-based patient engagement software and services. It offers cloud-based software and clinical pharmacist services through its brands, including MedWise, SinfoníaRx, RxCompanion, PrescribeWellness, and DoseMeRx. The company was founded by Calvin H. Knowlton, Orsula V. Knowlton, and Michael Greenhalgh in April 2009 and is headquartered in Moorestown, NJ.

Earnings data Q4 2019

Earnings data Q1 2020

Earnings data Q2 2020

Earnings data Q3 2020

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q2 2024

Tabula Rasa HealthCare reports robust Q4 growth and strategic investments

Tabula Rasa HealthCare's Q4 2022 performance reflects strong revenue growth and strategic initiatives to enhance profitability.
While facing challenges in technology-enabled solutions revenue and execution risks, the company is well-positioned for growth.
Opportunities in automation investments and MedWise platform expansion offer avenues for sustained revenue growth and market impact.

Tabula Rasa HealthCare (TRHC) excels in Q1 2023 earnings, eyes expansion

Tabula Rasa HealthCare (TRHC) delivered strong financial performance in Q1 2023, driven by revenue growth, profitability focus, and strategic initiatives.
The company faces challenges from drug price inflation and contract turnover impact but is well-positioned for future expansion and market penetration.
TRHC's emphasis on customer-centric strategies, PACE program growth, and efficient resource management sets the stage for continued success and revenue growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tabula Rasa provides state-of-the-art medication management through a combination of technology, science and services that reduces costs, improves the quality of care and decreases the risks associated with ineffective medication plans.

MOORESTOWN, N.J. , March 2, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, today announced that it completed the sale of its SinfoníaRx business to Cureatr, following the sale of its DoseMeRx business to an affiliate of Fairlong Capital LLC earlier this year.

Tabula Rasa HealthCare Completes the Sale of SinfoníaRx and DoseMeRx

MOORESTOWN, N.J. , Feb. 21, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), will hold a conference call and webcast to discuss its fourth quarter and full year 2022 financial results Tuesday, March 7, 2023 at 8:30 a.m.

Tabula Rasa HealthCare Schedules Fourth Quarter and Full Year 2022 Earnings Conference Call

Tabula Rasa Healthcare (TRHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Tabula Rasa Healthcare (TRHC) to Report Q4 Results: Wall Street Expects Earnings Growth

MOORESTOWN, N.J. , Jan. 19, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, was named among America's Greatest Workplaces 2023 for Diversity by Newsweek.

Newsweek Names Tabula Rasa HealthCare Among America's Greatest Workplaces for Diversity

Reports Preliminary Estimated Revenue from Continuing Operations of $82.0 - $83.0 Million for the Fourth Quarter of 2022, Continuing Strong 2022 Revenue Performance as Company Focuses on Core Business MOORESTOWN, N.J. , Jan. 17, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc. ("TRHC" or the "Company") (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, today reported preliminary unaudited estimated revenue from continuing operations for the quarter ended December 31, 2022.

Tabula Rasa HealthCare Announces Preliminary Estimated Fourth Quarter 2022 Revenues From Continuing Operations

Agreement with one of the nation's largest PACE programs underscores TRHC's momentum delivering PACE-specific products and services into this crucial market  MOORESTOWN, N.J. , Nov. 8, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC)  (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, today announced that the Center for Elders' Independence (CEI), a California PACE program of 30 years and one of the largest in the nation, has signed a three year agreement with TRHC for key PACE (Program of All-Inclusive Care for the Elderly) services, including comprehensive pharmacy and risk adjustment services to support their five centers and more than 1,000 participants in the East San Francisco Bay area.

Center for Elders' Independence Signs with TRHC for Key PACE Services

Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC ) Q3 2022 Results Conference Call November 4, 2022 8:30 AM ET Company Participants Frank Sparacino - SVP, Investor Relations & Corporate Development Brian Adams - President & Interim Chief Executive Officer Tom Cancro - Chief Financial Officer Conference Call Participants Sean Dodge - RBC Jared Haase - William Blair Stephanie David - SVB Securities David Grossman - Stifel Operator Good day, and thank you for standing by. Welcome to the Third Quarter 2022 Tabula Rasa HealthCare, Inc. Earnings Conference Call.

Tabula Rasa HealthCare, Inc. (TRHC) Q3 2022 Earnings Call Transcript

Tabula Rasa Healthcare (TRHC) delivered earnings and revenue surprises of -1,366.67% and 4.64%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Tabula Rasa Healthcare (TRHC) Reports Q3 Loss, Tops Revenue Estimates

Revenue from continuing operations of $77.1 million increased 14% vs. a year ago GAAP net loss from continuing operations of $25.9 million vs.

Tabula Rasa HealthCare Reports Third Quarter 2022 Results

MOORESTOWN, N.J. , Nov. 1, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, today announced the appointment of April D.

Tabula Rasa HealthCare Names April Gill Chief Commercial Officer

MOORESTOWN, N.J. , Oct. 26, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, was named a Champion of Board Diversity by The Forum of Executive Women (The Forum), which annually honors the top public companies in the Philadelphia region for having 30% or more women on their respective boards.

Tabula Rasa HealthCare Named a 2022 Champion of Board Diversity

MOORESTOWN, N.J. , Oct. 20, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (NASDAQ:TRHC), will hold a conference call and webcast to discuss its third quarter 2022 operating results Friday, November 4, 2022 at 8:30 a.m.

Tabula Rasa HealthCare Schedules Third Quarter 2022 Earnings Conference Call

Ron Mitchell, Co-Founder and CEO of Humanity Health, joins Board of Directors   MOORESTOWN, N.J. , Oct. 11, 2022 /PRNewswire/ --  Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, today announced that Ron Mitchell, co-founder and Chief Executive Officer of Humanity Health Inc. (Humanity Health), joined TRHC's Board of Directors (Board).

TRHC Adds Ron Mitchell to its Board of Directors

MOORESTOWN, N.J. , Sept. 21, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.®  (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, hosted its 2022 CareKinesis Clinical Advisory Panel (CAP) Meeting September 15-16 at its headquarters in Moorestown, NJ.

TRHC's Clinical Advisory Panel Meeting Provides Insights on PACE Pharmacy

iRobot

These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities.

IRobot and Tabula Rasa See Activist Action

Tabula Rasa HealthCare Announces Leadership Transition

Agreement Also Provides for Enhancements to the Company's Corporate Governance, Including a Commitment to Propose a De-Classification of the Board at the 2023 Annual Meeting MOORESTOWN, N.J. , Sept. 14, 2022 /PRNewswire/ --  Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ: TRHC), ("TRHC" or the "Company"), a leading healthcare technology company advancing the safe use of medications, today announced a cooperation agreement with Indaba Capital Management, L.P.

Tabula Rasa HealthCare Announces Cooperation Agreement with Indaba Capital Management to Refresh the Company's Leadership and Board of Directors

Tabula Rasa Healthcare (TRHC) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Here Is Why Bargain Hunters Would Love Fast-paced Mover Tabula Rasa Healthcare (TRHC)

Medication decision support helps identify potentially inappropriate medication MOORESTOWN, N.J. , Aug. 16, 2022 /PRNewswire/ -- A new peer-reviewed study from Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, shows that pharmacist recommendations driven by its unique medication decision support system, MedWise® Science, can help prescribers identify and reduce the levels of potentially inappropriate medications among older adults, reducing the risk of negative cognitive and physical outcomes.

New Study Demonstrates Benefit of Advanced Decision Support in Driving Pharmacist Recommendations to Reduce Medication Risk

SAN FRANCISCO--(BUSINESS WIRE)--Indaba Capital Management L.P. (together with its affiliates, “Indaba” or “we”), which is the largest shareholder of Tabula Rasa HealthCare Inc. (NASDAQ: TRHC) (“Tabula Rasa” or the “Company”) with an ownership interest of approximately 25% of the Company's outstanding shares, today issued an open letter to the independent members of the Company's Board of Directors (the “Board”): Samira K. Beckwith, Jan Berger, MD, MJ, Dennis K. Helling, PharmD, ScD, Kathy O'Bri

Indaba Issues Letter to Tabula Rasa's Independent Directors Regarding Their Apparent Prioritization of the Knowltons' Interests Over Shareholders' Interests

The mean of analysts' price targets for Tabula Rasa Healthcare (TRHC) points to a 79.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Does Tabula Rasa Healthcare (TRHC) Have the Potential to Rally 80% as Wall Street Analysts Expect?

Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC ) Q2 2022 Earnings Conference Call August 5, 2022 8:30 AM ET Company Participants Kevin Dill - Corporate Counsel Calvin Knowlton - Founder, Chairman and Chief Executive Officer Orsula Knowlton - Founder, President and Chief Marketing Officer Brian Adams - President Tom Cancro - Chief Financial Officer Conference Call Participants Thomas Keller - RBC Jared Haase - William Blair Jessica Tassan - Piper Sandler David Grossman - Stifel Operator Good day and welcome to the Second Quarter 2022 Tabula Rasa HealthCare, Inc. Earnings Conference Call. At this time, all participants are in a listen-only mode.

Tabula Rasa HealthCare, Inc.'s (TRHC) CEO Calvin Knowlton on Q2 2022 Results -Earnings Call Transcript

Tabula Rasa Healthcare (TRHC) delivered earnings and revenue surprises of -3,300% and 5.93%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Tabula Rasa Healthcare (TRHC) Reports Q2 Loss, Tops Revenue Estimates

Revenue from continuing operations of $72.6 million increased 13% vs. a year ago, driven by CareVention HealthCare revenue growth of 17%.

Tabula Rasa HealthCare Reports Second Quarter 2022 Results

After losing some value lately, a hammer chart pattern has been formed for Tabula Rasa Healthcare (TRHC), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

News for Tabula Rasa Healthcare Stock (TRHC)